It had been more than twelve hours since the volunteer selection criteria announcement was posted, yet the entire world was still talking about it.
LucidNet had grown steadily over the past three weeks since the last Nova Night, with its user base surpassing 4.7 billion. The announcement was experiencing engagement levels that would have strained any other platform — driven by a rare moment of global, simultaneous attention focused on a single subject.
In less than twelve hours, more than three million people had applied for the clinical trial. And that number was climbing by the second.
The word on everyone's lips was the volunteer selection criteria, both online and offline. Everything else felt secondary.
Product launches were being quietly delayed by companies that understood there was no competing for attention right now.
